International Pharma Congresses during Covid-19

Lorenzo Fanti, Legal Counsel, Novartis AG, Argentina
Gregor von Arx, Global Head Legal, Neuroscience & Estab. Meds., Novartis Pharma AG, Switzerland
Geraldine Benjamin, English Solicitor, Bailhache Labesse Trustees Ltd, UK
Lorenzo Fanti, Legal Counsel, Novartis AG, Argentina

Pharmaceutical congresses and conferences are one of the preferred resources for medical doctors and healthcare professionals (both, “HCP” or “HCPs”) to learn about new research, treatments and indications . In 2020, and for the foreseeable future, these congresses have and will become ‘virtual’ in response to the COVID-19 pandemic. International pharmaceutical congresses invite a multinational group of medical experts and professionals with the objective of increasing the knowledge and expertise in therapeutic disease areas, facilitating exchange and ultimately advancing science and patient care. The Medical Association/Society is the organizer and the ‘owner’ of the congress. They are responsible for attendee management, access and other relevant criteria such as the overall scientific agenda.

Read full paper Subscribe to the IICJ
Argentina Switzerland Marketing Healthcare January 2021 Vol.14, No. 54, Winter 2021

Lorenzo Fanti

More

Gregor von Arx

More

https://www.linkedin.com/in/gregor-von-arx-7b426b7/

Geraldine Benjamin

More

Lorenzo Fanti

More

Novartis Pharma AG

More

Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company. https://www.novartis.com/our-company

Novartis AG

More

Argentina Switzerland Marketing Healthcare January 2021 Vol.14, No. 54, Winter 2021